Spots Global Cancer Trial Database for platinum based chemotherapy
Every month we try and update this database with for platinum based chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer | NCT06234748 | Oropharynx Canc... HPV-Related Car... | Radiation Platinum based ... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Itraconazole in Non Small Cell Lung Cancer | NCT03664115 | Lung Cancer | Itraconazole 20... Chemotherapy | 18 Years - | Ain Shams University | |
| LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC | NCT06216301 | Metastatic Non-... | NovoTTF-200T Pembrolizumab Platinum based ... | 18 Years - | NovoCure Ltd. | |
| The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer | NCT06000358 | Lung Cancer Sta... | Bronchoscopic c... Pembrolizumab Platinum based ... | 18 Years - 99 Years | Lithuanian University of Health Sciences | |
| LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC | NCT06216301 | Metastatic Non-... | NovoTTF-200T Pembrolizumab Platinum based ... | 18 Years - | NovoCure Ltd. | |
| TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | NCT06236425 | Squamous Cell C... Metastatic Squa... | TBio-4101 Pembrolizumab Platinum based ... Cyclophosphamid... Fludarabine Aldesleukin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer | NCT03043599 | Small Cell Lung... Extensive-stage... | Thoracic Radiat... Ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | NCT06236425 | Squamous Cell C... Metastatic Squa... | TBio-4101 Pembrolizumab Platinum based ... Cyclophosphamid... Fludarabine Aldesleukin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer | NCT04821778 | Esophagus Cance... Esophagogastric... Chemoradiation Targeted Therap... Immunotherapy Chemotherapy Ef... | Radiotherapy Platinum based ... Paclitaxel base... Immunotherapy 5-FU Analog bas... Nimotuzumab | 18 Years - | ChineseAMS | |
| LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC | NCT06216301 | Metastatic Non-... | NovoTTF-200T Pembrolizumab Platinum based ... | 18 Years - | NovoCure Ltd. | |
| Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | NCT03663166 | Carcinoma, Non-... | Thoracic Radiot... Platinum Based ... ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC | NCT06424899 | Non Small Cell ... | Adebrelimab radical chemora... Platinum based ... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer | NCT06234748 | Oropharynx Canc... HPV-Related Car... | Radiation Platinum based ... | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC | NCT06424899 | Non Small Cell ... | Adebrelimab radical chemora... Platinum based ... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) | NCT05657873 | Non Small Cell ... Non Small Cell ... Non-small Cell ... NSCLC NSCLC Stage IV | L-SABR Anti-PD-(L)1 ba... Platinum based ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer | NCT06000358 | Lung Cancer Sta... | Bronchoscopic c... Pembrolizumab Platinum based ... | 18 Years - 99 Years | Lithuanian University of Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
